vs
LXP Industrial Trust（LXP）与Nutex Health, Inc.（NUTX）财务数据对比。点击上方公司名可切换其他公司
Nutex Health, Inc.的季度营收约是LXP Industrial Trust的1.7倍（$151.7M vs $86.7M），LXP Industrial Trust净利率更高（33.2% vs 7.8%，领先25.4%），LXP Industrial Trust同比增速更快（-14.0% vs -41.1%），过去两年Nutex Health, Inc.的营收复合增速更高（50.0% vs 0.3%）
LXP工业信托是一家公开上市的房地产投资信托，专注于持有、运营和投资美国核心市场的优质工业地产，主要涵盖配送中心、物流设施及轻型工业物业，服务电商、第三方物流、先进制造等领域租户，为投资者创造长期稳定收益。
Nutex Health是一家总部位于美国得克萨斯州休斯敦的营利性医疗企业，核心业务为运营各类医疗机构，是美国本土医疗领域的专业运营机构，致力于为当地市场提供相关医疗服务与场地运营支持。
LXP vs NUTX — 直观对比
营收规模更大
NUTX
是对方的1.7倍
$86.7M
营收增速更快
LXP
高出27.1%
-41.1%
净利率更高
LXP
高出25.4%
7.8%
两年增速更快
NUTX
近两年复合增速
0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.7M | $151.7M |
| 净利润 | $28.8M | $11.8M |
| 毛利率 | 81.5% | 30.4% |
| 营业利润率 | 34.6% | 20.4% |
| 净利率 | 33.2% | 7.8% |
| 营收同比 | -14.0% | -41.1% |
| 净利润同比 | — | -80.8% |
| 每股收益（稀释后） | — | $2.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LXPNUTX
| Q4 25 | $86.7M | $151.7M | ||
| Q3 25 | $86.9M | $267.8M | ||
| Q2 25 | $87.7M | $244.0M | ||
| Q1 25 | $88.9M | $211.8M | ||
| Q4 24 | $100.9M | $257.6M | ||
| Q3 24 | $85.6M | $78.8M | ||
| Q2 24 | $85.8M | $76.1M | ||
| Q1 24 | $86.3M | $67.5M |
净利润LXPNUTX
| Q4 25 | $28.8M | $11.8M | ||
| Q3 25 | $36.3M | $55.4M | ||
| Q2 25 | $29.1M | $-17.7M | ||
| Q1 25 | $19.0M | $21.2M | ||
| Q4 24 | — | $61.6M | ||
| Q3 24 | $6.3M | $-8.8M | ||
| Q2 24 | $5.4M | $-364.0K | ||
| Q1 24 | $-269.0K | $-364.0K |
毛利率LXPNUTX
| Q4 25 | 81.5% | 30.4% | ||
| Q3 25 | 82.3% | 57.8% | ||
| Q2 25 | 81.9% | 51.2% | ||
| Q1 25 | 80.7% | 55.9% | ||
| Q4 24 | 85.3% | 55.0% | ||
| Q3 24 | 82.5% | 27.8% | ||
| Q2 24 | 82.0% | 29.7% | ||
| Q1 24 | 82.4% | 15.1% |
营业利润率LXPNUTX
| Q4 25 | 34.6% | 20.4% | ||
| Q3 25 | 50.4% | 48.7% | ||
| Q2 25 | 33.7% | 13.8% | ||
| Q1 25 | 21.8% | 38.1% | ||
| Q4 24 | — | 44.4% | ||
| Q3 24 | 7.9% | 12.3% | ||
| Q2 24 | 6.9% | 7.0% | ||
| Q1 24 | 1.0% | 2.1% |
净利率LXPNUTX
| Q4 25 | 33.2% | 7.8% | ||
| Q3 25 | 41.7% | 20.7% | ||
| Q2 25 | 33.2% | -7.3% | ||
| Q1 25 | 21.4% | 10.0% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | 7.4% | -11.2% | ||
| Q2 24 | 6.3% | -0.5% | ||
| Q1 24 | -0.3% | -0.5% |
每股收益（稀释后）LXPNUTX
| Q4 25 | — | $2.34 | ||
| Q3 25 | $0.12 | $7.76 | ||
| Q2 25 | $0.09 | $-2.95 | ||
| Q1 25 | $0.06 | $3.33 | ||
| Q4 24 | — | $11.56 | ||
| Q3 24 | $0.02 | $-1.72 | ||
| Q2 24 | $0.01 | $-0.07 | ||
| Q1 24 | $-0.01 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $170.4M | $185.6M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $2.0B | $329.4M |
| 总资产 | $3.5B | $918.5M |
| 负债/权益比越低杠杆越低 | 0.66× | — |
8季度趋势，按日历期对齐
现金及短期投资LXPNUTX
| Q4 25 | $170.4M | $185.6M | ||
| Q3 25 | $229.7M | $166.0M | ||
| Q2 25 | $71.0M | $96.7M | ||
| Q1 25 | $70.9M | $84.7M | ||
| Q4 24 | $101.8M | $40.6M | ||
| Q3 24 | $55.0M | $46.9M | ||
| Q2 24 | $48.7M | $40.8M | ||
| Q1 24 | $293.8M | $30.0M |
总债务LXPNUTX
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LXPNUTX
| Q4 25 | $2.0B | $329.4M | ||
| Q3 25 | $2.1B | $317.2M | ||
| Q2 25 | $2.1B | $235.3M | ||
| Q1 25 | $2.1B | $176.9M | ||
| Q4 24 | $2.1B | $132.4M | ||
| Q3 24 | $2.1B | $60.4M | ||
| Q2 24 | $2.1B | $62.7M | ||
| Q1 24 | $2.2B | $63.0M |
总资产LXPNUTX
| Q4 25 | $3.5B | $918.5M | ||
| Q3 25 | $3.7B | $964.5M | ||
| Q2 25 | $3.7B | $841.0M | ||
| Q1 25 | $3.8B | $761.9M | ||
| Q4 24 | $3.8B | $655.3M | ||
| Q3 24 | $3.9B | $438.5M | ||
| Q2 24 | $3.9B | $422.4M | ||
| Q1 24 | $4.2B | $404.3M |
负债/权益比LXPNUTX
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.73× | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $188.7M | $70.4M |
| 自由现金流经营现金流 - 资本支出 | — | $69.0M |
| 自由现金流率自由现金流/营收 | — | 45.5% |
| 资本支出强度资本支出/营收 | — | 0.9% |
| 现金转化率经营现金流/净利润 | 6.56× | 5.95× |
| 过去12个月自由现金流最近4个季度 | — | $245.6M |
8季度趋势，按日历期对齐
经营现金流LXPNUTX
| Q4 25 | $188.7M | $70.4M | ||
| Q3 25 | $63.5M | $99.5M | ||
| Q2 25 | $44.3M | $27.3M | ||
| Q1 25 | $39.0M | $51.0M | ||
| Q4 24 | $211.2M | $54.0K | ||
| Q3 24 | $64.6M | $6.8M | ||
| Q2 24 | $38.5M | $13.3M | ||
| Q1 24 | $38.9M | $3.1M |
自由现金流LXPNUTX
| Q4 25 | — | $69.0M | ||
| Q3 25 | — | $99.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $50.9M | ||
| Q4 24 | — | $-341.0K | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $12.7M | ||
| Q1 24 | — | $2.3M |
自由现金流率LXPNUTX
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 16.7% | ||
| Q1 24 | — | 3.4% |
资本支出强度LXPNUTX
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.1% |
现金转化率LXPNUTX
| Q4 25 | 6.56× | 5.95× | ||
| Q3 25 | 1.75× | 1.80× | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 2.05× | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | 10.18× | — | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LXP
暂无分部数据
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
